A little over a year ago, a possible lead to a treatment for Type I Diabetes was discovered. Researchers at Harvard University took a huge shortcut  from the universally common lead to a treatment. Instead of trying to put an embryonic stem cell into the beta cells, the researchers transformed normal pancreas cells into the beta cells by making active a trio of  dormant genes.

European and American researchers believe that pancreatic cells in diabetic mice can possibly be altered by the gene, Pax4. The beta cell levels were 8 times higher in treated mice. However, what is still unknown is why this therapy works best with mice that are less than one month old. But the therapy still counteracted all of the symptoms of Type I Diabetes in the mice.

One setback is the issue that the therapy may work too well. The diabetic mice have been left with a shortage of alpha cells due to the treatment. One thing is for certain, the treatment needs to be perfected before scientists can start testing this on humans. Those with Type I diabetes can be sure that scientists are working their hardest and coming close to curing the disease.